Serum complement protein C3 concentration is elevated in insulin resistance in obese men

European Journal of Internal Medicine

Volumn 11, Issue 1, 2000, Pages 21-26

  Koistinen, Heikki A ^a   Koivisto, Veikko A ^a   Ebeling, Pertti ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

ASP; C3; Complement; Diabetes; Insulin resistance; Obesity

Indexed keywords

COMPLEMENT COMPONENT C3A; GLUCOSE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DIET RESTRICTION; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; OBESITY;

EID: 0033951603     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(99)00064-3     Document Type: Article

References (25)

1. Thiel S., Vorup-Jensen T., Stover C.M., Schwaeble W., Laursen S.B., Poulsen K., Willis A.C., Eggleton P., Hansen S., Holmskov U., Reid K.B.M., Jensenius J.C. A second serine protease associated with mannan-binding lectin that activates complement. Nature. 386:1997;506-510.
2. Torzewski J., Bowyer D.E., Waltenberger J., Fitzsimmons C. Processes in atherogenesis: complement activation. Atherosclerosis. 132:1997;131-138.
3. Pomeroy C., Mitchell J., Eckert E., Raymond N., Crosby R., Dalmasso A.P. Effect of body weight and caloric restriction on serum complement proteins, including Factor D/adipsin: studies in anorexia nervosa and obesity. Clin Exp Immunol. 108:1997;507-515.
4. Muscari A., Bozzoli C., Puddu G.M., Rovinetti C., Fiorentini G.P., Roversi R.A., Puddu P. Correlations between serum lipids and complement components in adults without demonstrated atherosclerotic disease. Atherosclerosis. 81:1990;111-118.
5. Ylitalo K., Porkka K.V.K., Meri S., Nuotio I., Suurinkeroinen L., Vakkilainen J., Pajukanta P., Viikari J.S.A., Peltonen L., Ehnholm C., Taskinen M.-R. Serum complement and familial combined hyperlipidemia. Atherosclerosis. 129:1997;271-277.
6. Baumann H., Morella K.K., Wong G.H.W. TNF-α, IL-1β, and hepatocyte growth factor cooperate in stimulating specific acute phase plasma protein genes in rat hepatoma cells. J Immunol. 151:1993;4248-4257.
7. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
8. Pickup J.C., Mattock M.B., Chusney G.D., Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia. 40:1997;1286-1292.
9. Cianflone K., Roncari D.A.K., Maslowska M., Baldo A., Forden J., Sniderman A.D. Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry. 33:1994;9489-9495.
10. Maslowska M., Sniderman A.D., Germinario R., Cianflone K. ASP stimulates glucose transport in cultured human adipocytes. Int J Obes. 21:1997;261-266.
11. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 237:1979;E214-E223.
12. Ebeling P., Tuominen J.A., Bourey R., Koranyi L., Koivisto V.A. Athletes with IDDM exhibit impaired metabolic control and increased lipid utilization with no increase in insulin sensitivity. Diabetes. 44:1995;471-477.
13. Hotamisligil G.S., Spiegelman B.M. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes. 43:1994;1271-1278.
14. Miles P.D.G., Romeo O.M., Higo K., Cohen A., Rafaat K., Olefsky J.M. TNF-alpha induced insulin resistance in vivo and its prevention by troglitazone. Diabetes. 46:1997;1678-1683.
15. Sherman M.L., Spriggs D.R., Arthur K.A., Imamura K., Frei III E., Kufe D.W. Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism. J Clin Oncol. 6:1988;344-350.
16. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest. 95:1995;2409-2415.
17. Kern P.A., Saghizadeh M., Ong J.M., Bosch R.J., Deem R., Simsolo R.B. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest. 95:1995;2111-2119.
18. Saghizadeh M., Ong J.M., Garvey W.T., Henry R.R., Kern P.A. The expression of TNFα by human muscle. Relationship to insulin resistance. J Clin Invest. 97:1996;1111-1116.
19. Koivisto V.A., Pelkonen R., Cantell K. Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes. 38:1989;641-647.
20. Vgontzaz A.N., Papanicolaou D.A., Bixler E.O., Kales A., Tyson K., Chrousos G.P. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab. 82:1997;1313-1316.
21. Ferrannini E., Buzzigoli G., Bonadonna R., Giorico M.A., Oleggini M., Graziadei L., Pedrinelli R., Brandi L., Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 317:1987;350-357.
22. Dalekos G.N., Elisaf M., Bairaktari E., Tsolas O., Siamopoulos K.C. Increased serum levels of interleukin-1β in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients. J Lab Clin Med. 129:1997;300-308.
23. Bressler P., Bailey S.R., Matsuda M., DeFronzo R.A. Insulin resistance and coronary artery disease. Diabetologia. 39:1996;1345-1350.
24. Muscari A., Bozzoli C., Gerratana C., Faca F., Rovinetti C., Zauli D., La Placa M., Puddu P. Association of serum IgA and C4 with severe atherosclerosis. Atherosclerosis. 74:1988;179-186.
25. Seifert P.S., Kazatchkine M.D. The complement system in atherosclerosis. Atherosclerosis. 73:1988;91-104.